We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUY
176
DELISTED
Yamana Gold, Inc.
AUY
| $54.5M | 0.14% |
9,988,900
| – | – |
|
177
Biogen
BIIB
$30.9B
| $54.4M | 0.13% |
203,342
+58,606
| +40% | +$17.6M |
|
178
L3Harris
LHX
$55.4B
| $53.7M | 0.13% |
316,339
-595
| -0.2% | -$112K |
|
179
AMN Healthcare
AMN
$1.35B
| $53.2M | 0.13% |
1,175,919
+33,136
| +3% | +$1.58M |
|
180
Medtronic
MDT
$112B
| $52.4M | 0.13% |
571,335
-66,171
| -10% | -$6.35M |
|
181
Stryker
SYK
$135B
| $51.9M | 0.13% |
288,303
-72,829
| -20% | -$13.4M |
|
|
QTS
182
DELISTED
QTS REALTY TRUST, INC.
QTS
| $51.6M | 0.13% |
804,383
+123,947
| +18% | +$7.79M |
|
183
Chegg
CHGG
$116M
| $51.5M | 0.13% |
765,088
+355,088
| +87% | +$19M |
|
184
Domino's
DPZ
$11.9B
| $51.3M | 0.13% |
138,780
+56,375
| +68% | +$20.8M |
|
185
Baxter International
BAX
$12.8B
| $50.8M | 0.13% |
589,762
+10,659
| +2% | +$928K |
|
|
ALBO
186
DELISTED
Albireo Pharma Inc
ALBO
| $50.7M | 0.13% |
1,913,190
| – | – |
|
187
Rhythm Pharmaceuticals
RYTM
$7.31B
| $50.5M | 0.13% |
2,266,071
+171
| +0% | +$3.33K |
|
188
Natera
NTRA
$36.4B
| $50.5M | 0.13% |
1,013,500
-29
| -0% | -$1.16K |
|
189
Editas Medicine
EDIT
$399M
| $50.4M | 0.12% |
1,704,300
+267,500
| +19% | +$6.99M |
|
190
M&T Bank
MTB
$36.3B
| $50.4M | 0.12% |
484,404
+154,625
| +47% | +$16.3M |
|
191
Fortune Brands Innovations
FBIN
$5.86B
| $50.2M | 0.12% |
918,450
-85,575
| -9% | -$3.98M |
|
|
DEA
192
Easterly Government Properties
DEA
$1.16B
| $49.9M | 0.12% |
863,775
+28,367
| +3% | +$1.8M |
|
193
Adobe
ADBE
$105B
| $49.9M | 0.12% |
114,587
-3,753
| -3% | -$1.39M |
|
194
O'Reilly Automotive
ORLY
$75.1B
| $49.6M | 0.12% |
1,765,275
-223,110
| -11% | -$5.83M |
|
|
ENV
195
DELISTED
ENVESTNET, INC.
ENV
| $49.5M | 0.12% |
673,400
+53,000
| +9% | +$3.46M |
|
196
UnitedHealth
UNH
$382B
| $49.5M | 0.12% |
167,659
-3,025
| -2% | -$867K |
|
197
DXC Technology
DXC
$1.91B
| $48.9M | 0.12% |
2,966,004
+921,297
| +45% | +$14.7M |
|
198
Illumina
ILMN
$29.5B
| $48.6M | 0.12% |
134,832
-7,146
| -5% | -$2.3M |
|
199
Synopsys
SNPS
$71.6B
| $48M | 0.12% |
246,403
+136,274
| +124% | +$22.5M |
|
200
Nike
NKE
$64.1B
| $47.6M | 0.12% |
485,868
-97,811
| -17% | -$9.03M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.